Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Instil Bio, Inc.
(NQ:
TIL
)
8.260
-0.490 (-5.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Instil Bio, Inc.
< Previous
1
2
3
4
5
6
Next >
Instil Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 13, 2025
From
Instil Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
April 25, 2025
Via
Benzinga
Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 04, 2025
From
Instil Bio
Via
GlobeNewswire
Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody
January 14, 2025
From
Instil Bio
Via
GlobeNewswire
TIL Stock Earnings: Instil Bio Beats EPS for Q2 2024
↗
August 13, 2024
TIL stock results show that Instil Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
TIL Stock Earnings: Instil Bio Beats EPS for Q4 2023
↗
March 21, 2024
TIL stock results show that Instil Bio beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
↗
January 07, 2025
Jefferies upgrades Instil Bio to "Buy" with a $52 target, anticipating significant growth for PD-(L)1xVEGF class and SYN2510's potential in cancer treatments.
Via
Benzinga
Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 13, 2024
From
Instil Bio
Via
GlobeNewswire
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?
↗
October 24, 2024
This drugmaker's lead candidate could become a top-selling cancer therapy.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 08, 2024
Via
Benzinga
2 Stocks Up Over 700% in 2024 That Could Soar Even Further
↗
September 25, 2024
These relatively small companies are developing new cancer therapies that could generate billions in annual sales.
Via
The Motley Fool
TIL Stock Earnings: Instil Bio Beats EPS for Q2 2023
↗
December 13, 2023
TIL stock results show that Instil Bio beat analyst estimates for earnings per share the second quarter of 2023.
Via
InvestorPlace
Steelcase Reports Weak Sales, Joins American Healthcare REIT And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
September 19, 2024
Via
Benzinga
Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
September 17, 2024
Via
Benzinga
Here's Why Everyone's Talking About Summit Therapeutics
↗
September 17, 2024
Find out why positive results from a Summit Therapeutics study keep pushing up BioNTech and Instil Bio stock.
Via
The Motley Fool
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
↗
September 16, 2024
Via
Benzinga
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
September 16, 2024
Via
Benzinga
Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer
September 16, 2024
From
Instil Bio
Via
GlobeNewswire
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher?
↗
September 14, 2024
A candidate that Instil Bio in-licensed this August is similar to a candidate that recently outperformed the world's top-selling cancer therapy.
Via
The Motley Fool
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday
↗
September 12, 2024
Via
Benzinga
Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 13, 2024
From
Instil Bio
Via
GlobeNewswire
Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal
↗
August 03, 2024
Shanghai ImmuneOnco Biopharma out-licensed global rites (ex-China) for two of its antibodies to Instil Bio of Dallas, Texas. ImmuneOnco will receive an upfront and near-term payments of $50 million,...
Via
Talk Markets
Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody
August 01, 2024
From
Instil Bio
Via
GlobeNewswire
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
July 12, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
July 12, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via
InvestorPlace
TIL Stock Earnings: Instil Bio Misses EPS for Q1 2024
↗
May 10, 2024
TIL stock results show that Instil Bio missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 10, 2024
From
Instil Bio
Via
GlobeNewswire
Instil Bio Announces Strategic Update
January 16, 2024
From
Instil Bio
Via
GlobeNewswire
TIL Stock Earnings: Instil Bio Misses EPS for Q1 2023
↗
December 13, 2023
TIL stock results show that Instil Bio missed analyst estimates for earnings per share the first quarter of 2023.
Via
InvestorPlace
TIL Stock Earnings: Instil Bio Misses EPS for Q3 2023
↗
December 13, 2023
TIL stock results show that Instil Bio missed analyst estimates for earnings per share the third quarter of 2023.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
